Drew Weissman is an American physician and immunologist renowned for his groundbreaking work in RNA biology, particularly his contributions to the development of mRNA vaccines. He holds prestigious positions at the University of Pennsylvania, including the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine. His research has been instrumental in advancing the field of RNA technology and has had a profound impact on global health.
Drew Weissman was born on September 7, 1959, in Lexington, Massachusetts.
Drew Weissman graduated from Lexington High School in 1977.
Drew Weissman received his B.A. and M.A. degrees from Brandeis University in 1981, majoring in biochemistry and enzymology.
In 1987, Drew Weissman earned his M.D. and Ph.D. degrees from Boston University, focusing on immunology and microbiology.
In 1997, Drew Weissman moved to the University of Pennsylvania and established his laboratory to study RNA and innate immune system biology.
Beginning in 2005, Drew Weissman and Katalin Karikó published landmark studies on using synthetic nucleosides to modify RNA and prevent its degradation, laying the groundwork for RNA therapeutics.
Drew Weissman and Katalin Karikó co-founded RNARx in 2006 to develop novel RNA therapies.
In 2020, Weissman and Karikó were awarded the Rosenstiel Award, among other awards for their mRNA-related work.
In 2020, Weissman and Karikó's modified RNA technology became a key component of the Pfizer/BioNTech and Moderna COVID-19 vaccines.
Drew Weissman received the Princess of Asturias Award in the category for Scientific Research in 2021.
Drew Weissman was elected to the National Academy of Medicine and the American Academy of Arts and Sciences in 2022.
In 2022, Weissman received the Breakthrough Prize in Life Sciences, the Jessie Stevenson Kovalenko Medal, and several other awards.
Weissman and Karikó were awarded the Novo Nordisk Prize in 2022.
Drew Weissman received the Harvey Prize from the Technion in Israel in 2023 (awarded for the year 2021).
In 2023, Drew Weissman and Katalin Karikó were awarded the Nobel Prize in Physiology or Medicine for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Weissman and Karikó received the 2023 Nobel Prize in Physiology or Medicine, among other awards, for their mRNA-related work.